Aktuelle Version vom 12. April 2021, 18:49 Uhr
avoid white leds only 3000K or less
| 32395713 2020. Melatonin Inhibits COVID-19-induced Cytokine Storm by Reversing Aerobic Glycolysis in Immune Cells: A Mechanistic Analysis.
|
| 32597503 2020. Melatonin Restores Neutrophil Functions and Prevents Apoptosis amid Dysfunctional Glutathione Redox System.
|
32217117 2020. COVID-19: Melatonin as a potential adjuvant treatment
32360622 2020. Comment on Melatonin as a potential adjuvant treatment for COVID-19
32334009 2020. Correspondence COVID-19: Melatonin as a potential adjuvant treatment
32347747 2020. Can melatonin reduce the severity of COVID-19 pandemic?
32314850 2020. Melatonin: Roles in influenza, Covid?19, and other viral infections
32422305 2020. Lungs as target of COVID-19 infection: Protective common molecular mechanisms of vitamin D and melatonin as a new potential synergistic treatment.
32574327 2020. Therapeutic Algorithm for Use of Melatonin in Patients With COVID-19.
32519764 2020. Could melatonin be used in COVID-19 patients with laryngopharyngeal reflux disease?
32593625 2020. Melatonin, coronavirus, cardiovascular disease, and the geriatric emergency: let's use everything we have!
32657483 2020. Pharmacological agents under investigation in the treatment of coronavirus disease 2019 and the importance of melatonin.
32679150 2020. Matrix metallopeptidase 9 as a host protein target of chloroquine and melatonin for immunoregulation in COVID-19: A network-based meta-analysis.
32768324 2020. Melatonin, coronavirus, cardiovascular disease, and the geriatric emergency: let's use everything we have! Response.
| 32768490 2020. Melatonin potentials against viral infections including COVID-19: Current evidence and new findings.
|
32770854 2020. Clinical trial to test the efficacy of melatonin in COVID-19.
32772307 2020. Coronavirus Disease 2019 (COVID-19) and Its Neuroinvasive Capacity: Is It Time for Melatonin?
32777902 2020. Melatonin, Aging and COVID-19: Could melatonin be beneficial for COVID-19 treatment in elderly?
| 32825327 2020. Melatonin's Impact on Antioxidative and Anti-Inflammatory Reprogramming in Homeostasis and Disease.
|
32836663 2020. Melatonina, coronavirus, enfermedad cardiovascular y emergencia geriatrica: inverted exclamation markusemos todo lo que tenemos!
32847033 2020. Clinical Trials for Use of Melatonin to Fight against COVID-19 Are Urgently Needed.
32863490 2020. Structural and physico-chemical evaluation of melatonin and its solution-state excited properties, with emphasis on its binding with novel coronavirus proteins.
32893686 2020. Melatonin as a putative protection against myocardial injury in COVID-19 infection.
32913393 2020. Possible role of tryptophan and melatonin in COVID-19.
32920757 2020. Role of melatonin in the treatment of COVID-19; as an adjuvant through cluster differentiation 147 (CD147).
32922174 2020. COVID-19: Rational discovery of the therapeutic potential of Melatonin as a SARS-CoV-2 main Protease Inhibitor.
32962929 2020. Melatonin: a fertility-friendly anti-coronavirus agent.
| 32972871 2020. Clinical study of novel coronavirus pneumonia prevention by melatonin.
|
| 32992875 2020. Targeting Host Defense System and Rescuing Compromised Mitochondria to Increase Tolerance against Pathogens by Melatonin May Impact Outcome of Deadly Virus Infection Pertinent to COVID-19.
|
33006999 2020. In-silico drug repurposing study predicts the combination of pirfenidone and melatonin as a promising candidate therapy to reduce SARS-CoV-2 infection progression and respiratory distress caused by cytokine storm.
33015537 2020. Elderly as a High-risk Group during COVID-19 Pandemic: Effect of Circadian Misalignment, Sleep Dysregulation and Melatonin Administration.
33108677 2020. Melatonin controversies, an update.
33256258 2020. Can Melatonin Be a Potential "Silver Bullet" in Treating COVID-19 Patients?
| 33269948 2020. New proposal involving nanoformulated melatonin targeted to the mitochondria as a potential COVID-19 treatment.
|
C7255217 ?. Reply to Delirium sleep COVID-19 and melatonin .
